JPMorgan International Research Enhanced Equity ETF is a ETF series of J.P. Morgan Exchange-Traded Fund Trust (series S000074054). Net assets $10.6B as of 2026-04-30.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| ASML Holding NV | — | $335.0M | 316.51% |
| JPMorgan Securities Lending Money Market Fund | — | $293.5M | 277.30% |
| AstraZeneca plc | — | $217.8M | 205.74% |
| Siemens AG | — | $176.9M | 167.16% |
| Shell plc | — | $168.9M | 159.58% |
| Allianz SE | — | $151.8M | 143.44% |
| HSBC Holdings plc | — | $151.5M | 143.09% |
| Nestle SA | — | $148.1M | 139.93% |
| Roche Holding AG | — | $134.9M | 127.41% |
| Banco Santander SA | — | $128.2M | 121.15% |
| Novartis AG | — | $126.5M | 119.54% |
| Toyota Motor Corp. | — | $124.3M | 117.48% |
| Air Liquide SA | — | $121.6M | 114.92% |
| Safran SA | — | $121.3M | 114.56% |
| UniCredit SpA | — | $120.0M | 113.41% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $10.6B |
| 2026-01-31 | $10.0B |
| 2025-10-31 | $9.1B |
| 2025-07-31 | $7.7B |
| 2025-04-30 | $6.9B |
| 2025-01-31 | $6.7B |
| 2024-10-31 | $6.4B |
| 2024-07-31 | $6.8B |